Insider · CIK 0001831218

Bohen Sean

Reports to the SEC for 1 company · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001831218

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-02	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+850K sh	—	—	850,000
2026-02-02	OLMAOlema Pharmaceuticals, Inc. · Performance Stock Options (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+275K sh	—	—	275,000
2025-12-26	OLMAOlema Pharmaceuticals, Inc.G Gift	Director, PRESIDENT AND CEO	GGift	−8,500 sh	—	—	237,650
2025-02-28	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+650K sh	—	—	650,000
2024-12-11	OLMAOlema Pharmaceuticals, Inc.S Sale	Director, PRESIDENT AND CEO	SSale	−55.9K sh	$8.66	−$484K	242,929
2024-12-11	OLMAOlema Pharmaceuticals, Inc.S Sale	Director, PRESIDENT AND CEO	SSale	−1,267 sh	$9.39	−$11.9K	241,662
2024-12-10	OLMAOlema Pharmaceuticals, Inc.S Sale	Director, PRESIDENT AND CEO	SSale	−52.3K sh	$9.37	−$490K	298,836
2024-12-09	OLMAOlema Pharmaceuticals, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+205K sh	—	—	351,164
2024-02-01	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+622K sh	—	—	621,500
2023-11-22	OLMAOlema Pharmaceuticals, Inc.S Sale	Director, PRESIDENT AND CEO	SSale	−27.9K sh	$13.90	−$388K	144,925
2023-11-21	OLMAOlema Pharmaceuticals, Inc.S Sale	Director, PRESIDENT AND CEO	SSale	−26.7K sh	$14.84	−$396K	175,459
2023-11-21	OLMAOlema Pharmaceuticals, Inc.S Sale	Director, PRESIDENT AND CEO	SSale	−2,602 sh	$15.29	−$39.8K	172,857
2023-11-20	OLMAOlema Pharmaceuticals, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+110K sh	—	—	202,150
2023-02-01	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+550K sh	—	—	550,000
2022-09-21	OLMAOlema Pharmaceuticals, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+20K sh	—	—	74,279
2022-09-21	OLMAOlema Pharmaceuticals, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+20K sh	—	—	74,279
2022-02-01	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+812K sh	—	—	812,250
2021-10-14	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+5,000 sh	$4.82	+$24.1K	57,514
2021-10-14	OLMAOlema Pharmaceuticals, Inc.S Sale	Director, PRESIDENT AND CEO	SSale	−4,649 sh	$30.42	−$141K	52,865
2021-10-14	OLMAOlema Pharmaceuticals, Inc.S Sale	Director, PRESIDENT AND CEO	SSale	−351 sh	$31.17	−$10.9K	52,514
2021-10-14	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−5,000 sh	—	—	966,316
2021-09-27	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+1,085 sh	$4.82	+$5,234.04	53,599
2021-09-27	OLMAOlema Pharmaceuticals, Inc.S Sale	Director, PRESIDENT AND CEO	SSale	−1,085 sh	$30.07	−$32.6K	52,514
2021-09-27	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−1,085 sh	—	—	971,316
2021-09-08	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+2,631 sh	$4.82	+$12.7K	56,905
2021-09-08	OLMAOlema Pharmaceuticals, Inc.S Sale	Director, PRESIDENT AND CEO	SSale	−2,631 sh	$30.00	−$78.9K	52,514
2021-09-08	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−2,631 sh	—	—	972,401
2021-09-07	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+413 sh	$4.82	+$1,992.312	54,687
2021-09-07	OLMAOlema Pharmaceuticals, Inc.S Sale	Director, PRESIDENT AND CEO	SSale	−413 sh	$30.08	−$12.4K	54,274
2021-09-07	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−413 sh	—	—	975,032
2021-09-01	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+871 sh	$4.82	+$4,201.704	55,145
2021-09-01	OLMAOlema Pharmaceuticals, Inc.S Sale	Director, PRESIDENT AND CEO	SSale	−871 sh	$30.05	−$26.2K	54,274
2021-09-01	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−871 sh	—	—	975,445
2021-03-15	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+75K sh	—	—	75,000
2020-11-18	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+538K sh	—	—	538,020
2020-09-23	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+51.6K sh	$4.82	+$249K	51,649
2020-09-23	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−51.6K sh	—	—	976,316
2020-09-19	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+82.9K sh	—	—	82,931
2020-09-19	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+1.03M sh	—	—	1,027,965

Recent filings

Accepted (ET)
Feb 44
Bohen Sean0001831218-26-000002
SEC(opens sec.gov)
Dec 304
Bohen Sean0001831218-25-000004
SEC(opens sec.gov)
Mar 34
Bohen Sean0001415889-25-006147
SEC(opens sec.gov)
Dec 114
Bohen Sean0001415889-24-029024
SEC(opens sec.gov)
Feb 54
Bohen Sean0001415889-24-002607
SEC(opens sec.gov)
Nov 224
Bohen Sean0001415889-23-015456
SEC(opens sec.gov)
Feb 24
Bohen Sean0001209191-23-006284
SEC(opens sec.gov)
Sep 234/A
Bohen Sean0001415889-22-009915
SEC(opens sec.gov)
Sep 224
Bohen Sean0001415889-22-009880
SEC(opens sec.gov)
Feb 34
Bohen Sean0001415889-22-001055
SEC(opens sec.gov)
Oct 154
Bohen Sean0001415889-21-004885
SEC(opens sec.gov)

Companies

Olema Pharmaceuticals, Inc.Director, PRESIDENT AND CEOOLMA

Address

C/O OLEMA PHARMACEUTICALS, INC. 780 BRANNAN ST

SAN FRANCISCO, CA, 94103